Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT (Q34995973)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT (English)

1 reference

Europe PubMed Central

5 August 2017

prostate carcinoma

1 reference

based on heuristic

inferred from title

David M Schuster

object named as

David M Schuster

1

0 references

F. DuBois Bowman

10

object named as

F DuBois Bowman

1 reference

Europe PubMed Central

5 August 2017

author name string

Bital Savir-Baruch

2

1 reference

Europe PubMed Central

5 August 2017

Peter T Nieh

3

1 reference

Europe PubMed Central

5 August 2017

Viraj A Master

4

1 reference

Europe PubMed Central

5 August 2017

Raghuveer K Halkar

5

1 reference

Europe PubMed Central

5 August 2017

Peter J Rossi

6

1 reference

Europe PubMed Central

5 August 2017

Melinda M Lewis

7

1 reference

Europe PubMed Central

5 August 2017

Jonathon A Nye

8

1 reference

Europe PubMed Central

5 August 2017

Weiping Yu

9

1 reference

Europe PubMed Central

5 August 2017

Mark M Goodman

11

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

14 April 2011

1 reference

Europe PubMed Central

5 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

5 August 2017

259

1 reference

Europe PubMed Central

5 August 2017

852-861

1 reference

Europe PubMed Central

5 August 2017

3

1 reference

Europe PubMed Central

5 August 2017

PET/CT Imaging and Radioimmunotherapy of Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Radionuclide and hybrid imaging of recurrent prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Role of MRI in follow-up after focal therapy for prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Salvage radiotherapy for patients with PSA relapse following radical prostatectomy: issues and challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Outcomes following negative prostate biopsy for patients with persistent disease after radiotherapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

NCCN clinical practice guidelines in oncology: prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Positron emission tomography imaging of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Imaging of prostate cancer local recurrences: why and how?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Challenges in clinical prostate cancer: role of imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Novel tracers and their development for the imaging of metastatic prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Tumor cell metabolism imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Indium-111 capromab pendetide in the management of recurrent prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

The roles of PET and PET/CT in the diagnosis and management of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Update on fused capromab pendetide imaging of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Update on magnetic resonance imaging, ProstaScint, and novel imaging in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Positron emission tomography for prostate, bladder, and renal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Improved synthesis of anti-[18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Variable histology of anastomotic biopsies with detectable prostate specific antigen after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

8 July 2018

Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

26 October 2018

MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

26 October 2018

Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

26 October 2018

Progress in SPECT/CT imaging of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

26 October 2018

2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

26 October 2018

Detection of prostate cancer with 11C-methionine positron emission tomography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

26 October 2018

Predictors of metastatic disease in men with biochemical failure following radical prostatectomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

26 October 2018

Synthesis of syn- and anti-1-amino-3-[18F]fluoromethyl-cyclobutane-1-carboxylic acid (FMACBC), potential PET ligands for tumor detection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

26 October 2018

Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

26 October 2018

Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

26 October 2018

Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099047

26 October 2018

Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21493787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Long-Term Clinical Impact of Biochemical Recurrence of Prostate Cancer 5 or More Years After Radical Prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21493787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PROSTASCINT scan for staging prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21493787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21493787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indium-111-capromab pendetide scans: an important test relevant to clinical decision making

1 reference

https://pubmed.ncbi.nlm.nih.gov/21493787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Localization of Recurrent Prostate Cancer After External Beam Radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21493787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21493787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21493787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How to improve the ability to detect pelvic lymph node metastases of urologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21493787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21493787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide

1 reference

https://pubmed.ncbi.nlm.nih.gov/21493787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21493787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1148/RADIOL.11102023

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34995973&oldid=1980599365"